More from these Authors

• Technical Note | HBS Case Collection | November 2019

  The Life Sciences Revolution: A Technical Primer

  Gary P. Pisano, William J. Anderson, Amitabh Chandra, Clarissa Ceruti and Stephanie Oestreich

  For more than two decades, scientific advances have been driving profound changes in drug discovery and the drug industry itself. This case provides an overview and description of these technical and scientific advances. Written for the nonscientific reader, it may be used as companion reading for other case materials that require basic knowledge of the tools, techniques, and approaches used in the pharmaceutical and biotechnology industries.

  Keywords: Science; Technological Innovation; Technology; Pharmaceutical Industry; Biotechnology Industry;

  Citation:

  Pisano, Gary P., William J. Anderson, Amitabh Chandra, Clarissa Ceruti, and Stephanie Oestreich. "The Life Sciences Revolution: A Technical Primer." Harvard Business School Technical Note 620-054, November 2019.  View Details

  CiteView DetailsEducators

  Related

• Article | NEJM Catalyst | October 14, 2019

  How Artificial Intelligence Is Changing Health Care Delivery

  Samantha F. Sanders, Mats Terwiesch, William J. Gordon and Ariel Dora Stern

  The development of intelligent machines holds great promise for making health care delivery more accurate, efficient, and accessible, but challenges remain for incorporating AI into clinical and administrative settings.

  Keywords: artificial intelligence; Health Care and Treatment; Service Delivery; Technological Innovation;

  Citation:

  Sanders, Samantha F., Mats Terwiesch, William J. Gordon, and Ariel Dora Stern. "How Artificial Intelligence Is Changing Health Care Delivery." NEJM Catalyst (October 17, 2019).  View Details

  CiteView Details Read Now

  Related

• Case | HBS Case Collection | September 2019

  Adaptive Platform Trials: The Clinical Trial of the Future? (B)

  Ariel D. Stern and Sarah Mehta

  This case provides an update to the (A) case, which introduces students to adaptive platform trials, an ambitious, more efficient type of clinical trial that increases access to therapies. The A case centers on Dr. Brian Alexander’s efforts to launch an adaptive platform trial for studying potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. The (B) case provides an update and explores the strategies that Alexander is considering for sustainably financing this trial.

  Keywords: clinical trials; Drug Trials; Drug Testing; Cancer Trials; glioblastoma; platform trials; adaptive trials; adaptive platform trials; Health Testing and Trials; Health Care and Treatment; Business Strategy; Health Industry; United States;

  Citation:

  Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future? (B)." Harvard Business School Case 620-001, September 2019.  View Details

  CiteView DetailsEducators

  Related